| Subsidiary | Jurisdiction of Incorporation | |||||||
Escient Pharmaceuticals, Inc. | Delaware | |||||||
Escient Pharmaceuticals Australia Pty Ltd | Australia | |||||||
Incyte Holdings Corporation | Delaware | |||||||
Incyte Real Estate Holdings I LLC | Delaware | |||||||
Incyte Real Estate Holdings II LLC | Delaware | |||||||
Incyte Research Institute LLC | Delaware | |||||||
| Villaris Therapeutics Inc. | Delaware | |||||||
Incyte International Holdings Corporation | Delaware | |||||||
Incyte Biosciences Canada Corporation | Canada | |||||||
Incyte International Holdings S.à r.l. | Luxembourg | |||||||
Incyte Biosciences International S.à r.l. | Switzerland | |||||||
Incyte Biosciences Austria GmbH | Austria | |||||||
Incyte Biosciences Denmark ApS | Denmark | |||||||
Incyte Biosciences Finland Oy | Finland | |||||||
Incyte Biosciences France | France | |||||||
Incyte Biosciences Germany GmbH | Germany | |||||||
Incyte Biosciences Italy S.R.L. | Italy | |||||||
Incyte Biosciences Distribution B.V. | Netherlands | |||||||
Incyte Biosciences Benelux B.V. | Netherlands | |||||||
Incyte Biosciences Norway AS | Norway | |||||||
Incyte Biosciences Iberia S.L. | Spain | |||||||
Incyte Biosciences Nordic AB | Sweden | |||||||
Incyte Biosciences Poland sp. z o.o. | Poland | |||||||
Incyte Biosciences UK Ltd | UK | |||||||
Incyte Biosciences Technical Operations S.à r.l. | Switzerland | |||||||
Incyte Biosciences Australia Pty Ltd | Australia | |||||||
Incyte Biosciences Japan G.K. | Japan | |||||||
Incyte Biosciences (Shanghai) Co., Ltd. | China | |||||||
| Jidochem S.à r.l. | Switzerland | |||||||
Incyte Corp — 10-K exhibit
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.